Heiden hired as AMAG CEO
This article was originally published in Scrip
Executive Summary
AMAG Pharmaceuticals has enlisted William Heiden as president and CEO and a member of the board of directors. Frank Thomas, who has served as interim CEO of the company since November 2011, will return to his role of executive vice-president and COO. Mr Heiden is the former president and CEO of GTC Biotherapeutics, where he will continue to serve as chair.